Cynthia G. Sawyez

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance

Erin E. Mulvihill, Emma M. Allister, Brian G. Sutherland et al. · Diabetes · 2009 · 292 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

Erin E. Mulvihill, Julia M. Assini, Justin K. Lee et al. · Diabetes · 2011 · 204 citations · Full text

Life Sciences, Endocrinology, Pharmacology +15

Naringenin Decreases Progression of Atherosclerosis by Improving Dyslipidemia in High-Fat–Fed Low-Density Lipoprotein Receptor–Null Mice

Erin E. Mulvihill, Julia M. Assini, Brian G. Sutherland et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 163 citations

Life Sciences, Nutritional Sciences, Pharmacology +17

Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr mice

Julia M. Assini, Erin E. Mulvihill, Brian G. Sutherland et al. · Journal of Lipid Research · 2012 · 138 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17

Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese Ldlr−/− mice

Amy C. Burke, Brian G. Sutherland, Dawn E. Telford et al. · Journal of Lipid Research · 2018 · 133 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17